ABEONA THERAPEUTICS INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-27.3M | $-21.9M | $-14.5M | $-26.8M | $4.4M | $-10.5M | $-2.5M | $-7.5M |
| Depreciation & Amortization | $741.0K | $825.0K | $551.0K | $11.0K | $3.0K | $419.0K | $233.0K | $238.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $500.0K | $677.0K | $538.0K | $9.0K | $0 | $362.0K | $212.0K | — |
| Stock-Based Compensation | — | — | $4.4M | $1.3M | $439.0K | $390.0K | $1.1M | $1.0M |
| Net Cash from Operating Activities | $-22.7M | $-13.0M | $-10.4M | $-1.6M | $1.0K | $-4.0M | $-7.6M | $-6.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $860.0K | $519.0K | $308.0K | $0 | $2.0K | $13.0K | $40.0K | $7.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-860.0K | $-519.0K | — | — | $-2.0K | $-13.0K | $-40.0K | $-7.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $92.4M | $42.5M | — | — | $29.0K | $1.9M | $3.1M | $13.3M |
| Net Change in Cash | $68.6M | $29.0M | $28.6M | $11.1M | $28.0K | $-2.1M | $-4.6M | $6.4M |
| Free Cash Flow | $-23.5M | $-13.5M | $-10.7M | $-1.6M | $-1.0K | $-4.0M | $-7.6M | $-6.9M |